Wells Fargo
HIMS icon

Wells Fargo’s Hims & Hers Health HIMS Stock Holding History

Wells Fargo’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4M Sell
559,389
-92,207
-14% -$2.48M ﹤0.01% 1668
2026
Q1 		$13.5M Sell
651,596
-315,681
-33% -$7.46M ﹤0.01% 1807
2025
Q4 		$31.4M Buy
967,277
+85,678
+10% +$3.67M 0.01% 1203
2025
Q3 		$50M Buy
881,599
+312,401
+55% +$16M 0.01% 914
2025
Q2 		$28.4M Buy
569,198
+386,682
+212% +$17.5M 0.01% 1177
2025
Q1 		$5.39M Buy
182,516
+4,307
+2% +$160K ﹤0.01% 2352
2024
Q4 		$4.31M Sell
178,209
-203,356
-53% -$5.04M ﹤0.01% 2553
2024
Q3 		$7.03M Buy
381,565
+133,468
+54% +$2.39M ﹤0.01% 2111
2024
Q2 		$5.01M Buy
248,097
+185,962
+299% +$3.09M ﹤0.01% 2247
2024
Q1 		$961K Buy
62,135
+15,111
+32% +$170K ﹤0.01% 3487
2023
Q4 		$419K Buy
47,024
+17,822
+61% +$132K ﹤0.01% 3978
2023
Q3 		$184K Sell
29,202
-36,860
-56% -$274K ﹤0.01% 4413
2023
Q2 		$621K Sell
66,062
-1,691
-2% -$16.8K ﹤0.01% 3782
2023
Q1 		$672K Buy
67,753
+67,750
+2,258,333% +$594K ﹤0.01% 3644
2022
Q4 		$19 Sell
3
-1,918
-100% -$10.9K ﹤0.01% 7294
2022
Q3 		$11K Sell
1,921
-1,324
-41% -$7.98K ﹤0.01% 5645
2022
Q2 		$14K Buy
3,245
+1,972
+155% +$8.41K ﹤0.01% 5612
2022
Q1 		$7K Sell
1,273
-704
-36% -$3.48K ﹤0.01% 6382
2021
Q4 		$13K Sell
1,977
-976
-33% -$7.06K ﹤0.01% 6452
2021
Q3 		$23K Sell
2,953
-5,968
-67% -$50.5K ﹤0.01% 5922
2021
Q2 		$97K Buy
8,921
+2,786
+45% +$33.1K ﹤0.01% 5312
2021
Q1 		$82K Sell
6,135
-58,843
-91% -$986K ﹤0.01% 5571
2020
Q4 		$949K Buy
64,978
+18,001
+38% +$200K ﹤0.01% 4066
2020
Q3 		$552K Buy
+46,977
New +$500K ﹤0.01% 4266

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo's HIMS Position: Q2 2026 in Review

Wells Fargo reduced its Hims & Hers Health (HIMS) stake by 14% in Q2 2026, selling an estimated $2.48M and leaving 559,389 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1668.

Wells Fargo first reported a position in HIMS in Q3 2020 and has held it in 24 quarters since. The position peaked at $50M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Wells Fargo held 559,389 shares of Hims & Hers Health worth $19.4M as of Q2 2026.
  • Wells Fargo sold 92,207 Hims & Hers Health shares in Q2 2026, an estimated $2.48M.
  • Hims & Hers Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1668 holding.
  • Wells Fargo first reported a position in Hims & Hers Health in Q3 2020 and has held it in 24 quarters since.
  • Wells Fargo's Hims & Hers Health position peaked at $50M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.